Lenvatinib plus pembrolizumab shows promise in solid tumours
The combination of lenvatinib plus pembrolizumab has shown promise in [...]
Cancer patients face delays in getting ‘innovative’ drugs
A recent report from the Institute of Cancer Research has [...]
Tivozanib has a better safety profile than other TKIs for the treatment of kidney cancer
A recent literature review and network meta-analysis of phase 2/3 [...]
Effect of obesity and being overweight on complications and survival after surgery in kidney cancer patients
A recent study published in the Journal of Endourology this [...]
Renal function after surgery for kidney cancer may impact cancer-specific survival
The results from a single-centre study reported in Clinical Genitourinary [...]
Sarcomatoid RCC – molecular features and new opportunities for treatment
Sarcomatoid renal cell carcinoma (RCC) is difficult to treat and [...]
The future of immunotherapy-based combinations for metastatic kidney cancer
The past decade or so has seen the development of [...]
Molecular genetics of renal cell carcinoma
Most renal cell carcinomas (RCC) are diagnosed from studying the [...]
Non-cancer drugs tested on cancer cells
© StockSnap.io Scientists at the Broad Institute of Massachusetts Institute [...]
Scientists discover a part of the immune system that may be used to treat all cancers
Scientists from the University of Cardiff have discovered part of [...]
